Fluorescence in situ hybridization (FISH) on peripheral blood smears for monitoring Philadelphia chromosome-positive chronic myeloid leukemia (CML) during interferon treatment: A new strategy for remission assessment

Genes Chromosomes and Cancer

Volumn 21, Issue 2, 1998, Pages 90-100

  Mühlmann, Josef ^a   Thaler, Josef ^b   Hilbe, Wolfgang ^b   Bechter, Oliver ^b   Erdel, Martin ^a   Utermann, Gerd ^a   Duba, Hans Christoph ^a  

^a UNIVERSITY OF INNSBRUCK   (Austria)

^b INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; CYTARABINE; DNA; HYDROXYUREA;

ADULT; AGED; ARTICLE; BLOOD SMEAR; BONE MARROW; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOGENETICS; DNA PROBE; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; LEUKEMIA REMISSION; MALE; METAPHASE; PHILADELPHIA 1 CHROMOSOME; PRIORITY JOURNAL;

EID: 0345487506     PISSN: 10452257     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2264(199802)21:2<90::AID-GCC3>3.0.CO;2-2     Document Type: Article

References (32)

1. Allan NC, Richards SM, Shepherd PC (1995) UK Medical Research Council randomised, multicentre trial of interferon-alpha n1 for chronic myeloid leukaemia: Improved survival irrespective of cytogenctic response. Lancet 345:1392-1397.
2. Altman DG (1991) Some common problems in medical research. In Altman DG (ed): Practical Statistics for Medical Research. New York: Chapmann and Hall, pp 397-439.
3. Amiel A, Yarkoni S, Slavin S, Or R, Lorberboum Galski H, Fejgin M, Nagler A (1994) Detection of minimal residual disease state in chronic myelogenous leukemia patients using fluorescence in situ hybridization. Cancer Genet Cytogenet 76:59-64.
4. Ariad S, Dajee D, Willem P, Bezwoda WR (1993) Lack of involvement of T-lymphocytes in the leukaemic population during prolonged chronic phase of Philadelphia chromosome positive chronic myeloid leukaemia. Leuk Lymphoma 10:217-221.
5. Arnoldus EP, Wiegant J, Noordermeer IA, Wessels JW, Beverstock GC, Grosveld GC, van der Ploeg M, Raap AK (1990) Detection of the Philadelphia chromosome in interphase nuclei. Cytogenet Cell Genet 54:108-111.
6. Bentz M, Cabot G, Moos M, Speicher MR, Ganser A, Lichter P, Döhner H (1994) Detection of chimeric BCR-ABL genes on bone marrow samples and blood smears in chronic myeloid and acute lymphoblastic leukemia by in situ hybridization. Blood 83:1922-1928.
7. Cabot GP, Bentz M, Scholl C, Moos M, Fischer K, Lichter P, Döhner H (1996) High incidence of a second BCR-ABL fusion in chronic myeloid leukemia revealed by interphase cytogenetic analysis on blood and bone marrow smears. Cancer Genet Cytogenet 87:107-111.
8. Cox Froncillo MC, Canronetti M, Masi M, Lentini R, Giudiceandrea P, Maffei L, Tribalto M, Amadori S, Papa G (1995) Cytogenetic analysis is non-informative for assessing the remission rate in chronic myeloid leukemia (CML) patients on interferon-alpha (IFN-alpha) therapy. Cancer Genet Cytogenet 84:15-18.
9. Cox Froncillo MC, Maffei L, Cantonetti M, Del Poeta G, Lentini R, Bruno A, Masi M, Tribalto M, Amadori S (1996) FISH analysis for CML monitoring? Ann Hematol 73:113-119.
10. Czepulkowski BH, Bhatt B, Rooney DE (1992) Basic techniques for the preparation and analysis of chromosomes from bone marrow and leukaemic blood. In Rooney DE, Czepulkowski BH (eds): Human Cytogenetics, A Practical Approach, vol 2. Oxford: Oxford University Press, pp 1-25.
11. Guo JQ, Lian JY, Xian YM, Lee MS, Deisseroth AB, Stass SA, Champlin RE, Talpaz M, Wang JY, Arlinghaus RB (1994) BCR-ABL protein expression in peripheral blood cells of chronic myelogenous leukemia patients undergoing therapy. Blood 83: 3629-3637.
12. Hehlmann R, Heimpel H, Hasford J, Kolb HJ, Pralle H, Hossfeld DK, Queisser W, Löffler H, Hochhaus A, Heinze B, Georgii A, Bartram CR, Grießhammer M, Bergmann L, Essers U, Falge C, Queißer U, Meyer P, Schmitz N, Eimermacher H, Walther F, Fett W, Kleeberg UR, Käbisch A, Nerl C, Zimmerman R, Meuret G, Tichelli A, Kanz L, Tigges FJ, Schmid L, Brockhaus W, Tobler A, Reiter A, Perker M, Emmerich B, Verpoort K, Zankovich R, v Wussow P, Prümmer O, Thiele J, Buhr T, Ansari H, and the German CML Study Group (1994) Randomized comparison of interferon-alpha with busulfan and hydroxyurea in chronic myelogenous leukemia (CML). Blood 84:4064-4077.
13. Hochhaus A, Lin F, Reiter A, Skladny H, Mason PJ, van Rhee F, Shepherd PC, Allan NC, Hehlmann R, Goldman JM, Cross NC (1996) Quantification of residual disease in chronic myelogenous leukemia patients on interferon-alpha therapy by competitive polymerase chain reaction. Blood 87:1549-1555.
14. Italian Cooperative Study Group on Chronic Myeloid Leukemia (1994) Interferon alfa-2a as compared with conventional chemotherapy for the treatment of chronic myeloid leukemia. N Engl J Med 330:820-825.
15. Kantarjian HM, Keating MJ, Talpaz M, Walters RS, Smith TL, Cork A, McCredie KB, Freireich EJ (1987) Chronic myelogenous leukemia in blast crisis. Analysis of 242 patients. Am J Med 83:445-454.
16. Kantarjian HM, Deisseroth A, Kurzrock R, Estrov Z, Talpaz M (1993) Chronic myelogenous leukemia: A concise update. Blood 82:691-703.
17. Kantarjian HM, Smith TL, O'Brien S, Beran M, Pierce S, Talpaz M (1995) Prolonged survival in chronic myelogenous leukemia after cytogenetic response to interferon-alpha therapy. Ann Intern Med 122:254-261.
18. Kurzrock R, Gutterman JU, Talpaz M (1988) The molecular genetics of Philadelphia chromosome-positive leukemias. N Engl J Med 319:990-998.
19. Majlis A, Smith TL, Talpaz M, O'Brien S, Rios MB, Kantarjian HM (1996) Significance of cytogenetic clonal evolution in chronic myelogenous leukemia. J Clin Oncol 14:196-203.
20. Nitta M, Kato Y, Strife A, Wachter M, Fried J, Perez, A, Jhanwar S, Duigou Osterndorf R, Chaganti RS, Clarkson B (1985) Incidence of involvement of the B and T lymphocyte lineages in chronic myelogenous leukemia. Blood 66:1053-1061.
21. Nolte M, Werner M, Ewig M, von Wasielcwski R, Wilkens L, Link H, Ganser A, Georgii A (1996) Fluorescence in situ hybridization (FISH) is a reliable diagnostic tool for detection of the 9;22 translocation. Leuk Lymphoma 22:287-294.
22. Nowell PC, Hungerford DA (1960) A minute chromosome in human chronic granulocytic leukemia. Science 132:1497.
23. Rowley JD (1973) A new consistent chromosomal abnormality in chronic myelogenous leukemia identified by quinacrine fluorescence and Giemsa staining. Nature 243:290-293.
24. Sadamori N, Matsunaga M, Yao E, Ichimaru M, Sandberg AA (1985) Chromosomal characteristics of chronic and blastic phases of Ph-positive chronic myeloid leukemia. Cancer Genet Cytogenet 15:17-24.
25. Seong DC, Kantarjian HM, Ro JY, Talpaz M, Xu J, Robinson JR, Deisseroth AB, Champlin RE, Siciliano MJ (1995) Hypermetaphase fluorescence in situ hybridization for quantitative monitoring of Philadelphia chromosome-positive cells in patients with chronic myelogenous leukemia during treatment. Blood 86:2343-2349.
26. Talpaz M, Kantarjian HM, McCredie KB, Keating MJ, Trujillo J, Gutterman J (1987) Clinical investigation of human alpha interferon in chronic myelogenous leukemia. Blood 69:1280-1288.
27. Thaler J, Gastl G, Fluckinger T, Niederwieser D, Huber H, Seewann H, Sill H, Lang A, Falk M, Duba C, Utermann G. Kühr T, Aulitzky W, Huber C, Austrian Biological Response Modifier (BRM) Study Group (1996) Interferon alpha-2c therapy of patients with chronic myelogenous leukemia: Long-term results of a multicenter phase-II study. Ann Hematol 72:349-355.
28. Thaler J, Hilbe W, Apfelbeck U, Linkesch W, Sill H, Seewann H, Pont J, Bernhart M, Stöger M, Niessner H, Abbrederis K, Geissler D, Hausmaninger H, Lin W, Ludwig H, Lang A, Duba C, Fluckinger T, Greil R, Grünewald K, Konwalinka G, Niederwieser D, Fridrik M (1997) Interferon-alpha-2C and LD Ara-C for the treatment of patients with CML: Results of the Austrian multicenter phase-II study. Leuk Res 1:75-80.
29. Tkachuk DC, Westbrook CA, Andreeff M, Donlon TA, Cleary ML, Suryanarayan K, Homge M, Redner A, Gray J, Pinkel D (1990) Detection of bcr-abl fusion in chronic myelogeneous leukemia by in situ hybridization. Science 250:559-562.
30. Torlakovic E, Litz CE, McClure JS, Brunning RD (1994) Direct detection of the Philadelphia chromosome in CD20-positive lymphocytes in chronic myeloid leukemia by tri-color immunophenotyping/FISH. Leukemia 8:1940-1943.
31. van Lom K, Hagemeijer A, Smit EM, Löwenberg B (1993) In situ hybridization on May-Grunwald Giemsa-stained bone marrow and blood smears of patients with hematologic disorders allows detection of cell-lineage-specific cytogenetic abnormalities. Blood 82: 884-888.
32. Verschraegen CF, Talpaz M, Hirsch Ginsberg CF, Pherwam R, Rios MB, Stass SA, Kantarjian HM (1995) Quantification of the breakpoint cluster region rearrangement for clinical monitoring in Philadelphia chromosome-positive chronic myeloid leukemia. Blood 85:2705-2710.